respiratori
syncyti
viru
rsv
signific
caus
morbid
human
date
effect
treatment
exist
current
prophylact
therapi
access
limit
effect
attenu
risk
rsv
infect
hypothes
bioengin
either
viru
particl
host
cell
via
coval
graft
methoxypoli
ethylen
glycol
mpeg
would
prevent
infect
end
antivir
effect
graft
concentr
linker
chemistri
polym
length
rsv
infect
assess
viral
modif
short
chain
polym
kda
significantli
effect
long
chain
kda
polym
contrast
modif
host
cell
small
polym
provid
protect
long
chain
polym
effect
prevent
infect
exampl
hour
postinfect
multipl
infect
graft
concentr
mm
kda
mpeg
decreas
infect
respect
importantli
viral
host
cell
pegyl
strategi
abl
provid
near
complet
protect
rsv
infect
nonpolar
polar
cell
conclus
mpegmodif
either
rsv
host
cell
highli
effect
prophylact
strategi
prevent
viral
infect
respiratori
syncyti
viru
rsv
contagi
viru
belong
famili
paramyxovirida
rsv
infect
nearli
children
first
two
year
life
major
caus
bronchiol
pneumonia
popul
result
rsv
infect
lead
caus
infant
hospit
western
world
date
limit
treatment
exist
sever
rsv
infect
safe
effect
rsv
vaccin
develop
inde
current
prophylact
treatment
limit
monthli
administr
human
mous
antirsv
antibodi
prepar
synagi
reduc
incid
sever
diseas
howev
due
expens
prepar
administ
infant
high
risk
sever
rsv
infect
previous
demonstr
coval
graft
methoxypoli
ethylen
glycol
mpeg
surfac
red
blood
cell
prevent
immunolog
recognit
term
immunocamouflag
without
alter
cell
lysi
morpholog
hemoglobin
oxid
state
furthermor
graft
mpeg
cell
prevent
allorecognit
cell
activ
demonstr
mpeg
graft
inhibit
receptorligand
interact
cell
surfac
protein
analog
allogen
receptorligand
interact
shown
direct
mpegmodif
simian
viru
prevent
host
cell
infect
furthermor
mpegmodif
host
cell
surfac
protein
protect
cell
viral
challeng
theiler
murin
encephalomyel
viru
tmev
mous
adenoviru
mav
rat
coronaviru
rcv
thu
sought
evalu
mpeg
graft
directli
either
rsv
host
cell
initi
phase
develop
prophylact
antirsv
nasal
spray
studi
investig
whether
mpegmodif
rsv
virion
host
cell
effect
strategi
prevent
viral
infect
strategi
evalu
broad
rang
viral
infect
dose
polar
nonpolar
host
cell
final
effect
particl
size
viru
versu
mammalian
cell
rel
antivir
efficaci
short
long
chain
graft
polym
investig
vero
hela
madindarbi
canin
kidney
mdck
cell
rsv
long
strain
purchas
american
type
cultur
collect
atcc
manassa
va
usa
recombin
green
fluoresc
protein
express
rsv
rgrsv
clone
deriv
rsv
strain
obtain
dr
peepl
nationwid
children
hospit
univers
ohio
columbu
ohio
dr
pl
collin
nation
institut
allergi
infecti
diseas
bethesda
maryland
vero
mdck
cell
grown
minim
essenti
media
mem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
fb
nonessenti
amino
acid
mem
vitamin
solut
lglutamin
mm
sodium
pyruv
gentamicin
mgml
invitrogen
hela
cell
grown
high
glucos
gl
dglucos
dulbecco
modifi
eagl
medium
dmem
supplement
fb
glutamaxi
mm
hepe
buffer
mm
penicillin
mgml
streptomycin
mgml
invitrogen
rsv
long
strain
rgrsv
grown
vero
hela
cell
respect
viral
stock
prepar
collect
supernat
lysedrsv
infect
cell
experi
cultur
rgrsv
media
lack
phenol
red
use
cyanur
chlorid
activ
mpeg
cmpeg
kda
purchas
sigmaaldrich
sigmaaldrich
oakvil
canada
succinimidyl
carbon
mpeg
scmpeg
kda
succinimidyl
valer
mpeg
svampeg
kda
fluoresceinlabel
kda
purchas
laysan
bio
incorpor
arab
al
usa
direct
viru
modif
rsv
long
strain
rgrsv
dilut
fbssupplement
mem
dmem
media
ph
respect
sampl
volum
adjust
yield
final
mpeg
graft
concentr
mm
indic
viral
multipl
infect
moi
concentr
polym
solut
prepar
immedi
prior
use
prevent
hydrolysi
linker
chemistri
derivat
reaction
done
room
temperatur
min
mpegmodifi
viru
solut
subsequ
overlaid
unmodifi
host
cell
min
c
gentl
rock
everi
min
unless
otherwis
note
host
cell
membran
surfac
modif
cell
grown
confluenc
prior
derivat
cell
rins
pb
subsequ
overlaid
media
ph
contain
freshli
prepar
activ
mpeg
indic
graft
concentr
cell
modifi
constant
volum
surfac
area
ratio
mlcm
incub
activ
mpeg
solut
min
room
temperatur
follow
modif
cell
rins
fbssupplement
media
challeng
unmodifi
viru
vero
cell
seed
tissu
cultur
plate
becton
dickenson
incub
confluent
cell
monolay
overlaid
ml
plaqu
form
unit
pfu
control
mpegmodifi
rsv
long
strain
min
c
viru
solut
remov
monolay
overlaid
prewarm
methylcellulos
sigma
fbssupplement
mem
media
cultur
plate
incub
day
c
prior
syncytia
count
minimum
three
independ
experi
duplic
sampl
conduct
viru
host
cell
modif
studi
rgrsv
use
challeng
nonpolar
hela
cell
hela
cell
seed
plate
becton
dickenson
incub
overnight
confluent
viru
host
cell
polym
kda
graft
conduct
describ
mpeg
concentr
mm
viral
challeng
studi
either
control
modifi
viru
min
overlay
control
modifi
host
hela
cell
minut
overlay
done
moi
sampl
incub
h
postchalleng
indic
time
point
cell
harvest
analyz
flow
cytometri
describ
previous
minimum
five
thousand
event
acquir
analys
conduct
gait
shaminfect
cell
moi
evalu
efficaci
mpeg
graft
viru
target
cell
polar
cell
model
mdck
cell
use
conjunct
rgrsv
mdck
cell
grown
confluenc
plate
challeng
either
mpeg
modifi
viru
subject
pegyl
prior
challeng
unmodifi
viru
viru
modif
rgrsv
pegyl
kda
svampeg
host
cell
modif
mdck
cell
pegyl
use
kda
svampeg
overcom
decreas
suscept
cell
line
rsv
infect
moi
use
cell
challeng
h
c
wash
overlaid
fbsmem
plate
incub
h
gfp
express
cell
visual
count
use
fluoresc
light
microscop
olympu
transmiss
electron
microscopi
tem
neg
stain
rgrsv
perform
use
hitachi
microscop
hitachi
high
technolog
america
inc
pleasanton
ca
usa
viru
concentr
equival
moi
rgrsv
modifi
kda
svampeg
ml
fbsmedia
ph
modif
viru
solut
load
amicon
centrifug
filter
unit
molecular
weight
cutoff
kda
millipor
corpor
bedford
usa
viru
concentr
accord
manufactur
instruct
subsequ
mpegmodifi
viru
dilut
stain
describ
previous
individu
viru
particl
visual
imag
captur
magnif
analys
spss
statist
softwar
statist
product
servic
solut
chicago
il
usa
use
twotail
pvalu
consid
statist
signific
data
viru
dose
experi
normal
unmodifi
mm
control
compar
experiment
procedur
data
requir
transform
raw
data
use
analysi
comparison
three
mean
oneway
analysi
varianc
anova
perform
signific
differ
found
posthoc
tukey
test
use
pairwis
comparison
mean
two
mean
compar
studentt
test
perform
determin
mpegmodif
rsv
inhibit
viral
infect
initi
perform
plaqu
assay
kda
cmpeg
shown
fig
cmpegmodif
rsv
decreas
number
syncytia
dosedepend
manner
determin
linker
chemistri
influenc
antivir
efficaci
investig
effect
kda
scand
svampeg
syncytia
format
fig
note
scmpeg
svampeg
result
dosedepend
decreas
number
syncytia
howev
rel
cmand
scmpeg
svampeg
result
significantli
greater
inhibit
rsv
infect
graft
concentr
p
except
mm
linker
chemistri
yield
nearli
complet
protect
importantli
demonstr
insert
fig
bind
mpegmodifi
rsv
target
cell
dramat
decreas
determin
immunofluoresc
stain
min
postchalleng
c
prevent
intern
evalu
effect
polym
length
rsv
inactiv
compar
kda
scmpeg
kda
svampeg
fig
polym
length
linker
chemistri
examin
graft
mpeg
result
dosedepend
decreas
number
syncytia
compar
two
polym
length
contain
sc
linker
chemistri
kda
mpeg
superior
kda
chain
graft
concentr
mm
p
importantli
mm
graft
concentr
kda
scmpeg
virtual
abolish
rsv
infect
kda
scmpeg
svalink
chemistri
provid
superior
protect
lower
graft
concentr
three
molecular
weight
kda
fig
statist
advantag
p
seen
kda
polym
kda
svampeg
mm
graft
concentr
thought
biolog
signific
importantli
high
mpeg
graft
concentr
mm
svampeg
speci
complet
prevent
rsv
infect
propag
determin
efficaci
antivir
prophylact
approach
effect
polym
graft
rsv
assess
broad
rang
moi
viru
moi
rang
modifi
kda
svampeg
hela
cell
challeng
fig
shown
high
moi
low
graft
concentr
svampeg
mm
either
kda
polym
ineffect
prevent
viral
invas
howev
graft
concentr
increas
mm
dosedepend
decreas
viral
infect
note
near
complet
abrog
infect
mm
interestingli
mm
graft
concentr
moi
kda
mpeg
polym
significantli
p
effect
prevent
viral
infect
kda
chain
fig
moi
decreas
rel
dosedepend
efficaci
mpeg
graft
increas
due
greater
polym
viru
ratio
ie
chain
per
viral
particl
interest
find
gener
trend
rsv
modif
short
chain
polym
kda
provid
improv
antivir
efficaci
long
kda
chain
polym
especi
lower
graft
concentr
eg
moi
mm
graft
concentr
p
higher
rsv
graft
concentr
mm
polym
length
yield
nearli
complet
protect
viral
infect
moi
across
moi
examin
graft
concentr
mm
produc
dramat
decreas
infect
per
unit
mm
mpeg
demonstr
viral
pegyl
simpli
disrupt
viru
particl
tem
studi
conduct
shown
fig
tem
qualit
studi
unmodifi
mm
mpegmodifi
mm
rgrsv
show
differ
number
viru
particl
data
shown
rsv
virion
structur
test
graft
concentr
agreement
previou
report
unmodifi
modifi
viru
rang
size
nm
taken
togeth
find
indic
mpeg
graft
dramat
disrupt
alter
size
rsv
virion
effect
prevent
viral
infect
rsv
specif
infect
polar
airway
epitheli
cell
vivo
vero
hela
cell
unpolar
evalu
mpegmodif
rsv
polar
mdck
cell
line
shown
fig
mpegmodif
mm
rgrsv
significantli
decreas
number
infect
cell
h
postinfect
p
furthermor
h
number
infect
cell
mm
control
increas
dramat
signific
increas
note
cell
challeng
mpegmodifi
viru
find
suggest
virion
manag
infect
cell
gener
signific
number
progeni
overcom
initi
reduct
infect
direct
pegyl
viru
particl
possibl
certain
circumst
eg
blood
deriv
product
red
cell
platelet
plasma
less
biolog
use
respiratori
virus
rsv
howev
induct
antivir
barrier
direct
pegyl
target
cell
eg
nasal
epitheli
cell
viru
would
signific
clinic
util
determin
activ
mpeg
result
uniform
derivat
cell
monolay
hela
cell
pegyl
use
mixtur
fluoresceinlabel
kda
mpeg
unlabel
kda
mpeg
examin
light
fluoresc
microscopi
shown
fig
light
microscopi
demonstr
control
mpegmodifi
cell
exhibit
normal
morpholog
fluoresc
microscopi
mpegmodifi
cell
demonstr
uniform
fluoresc
increas
mpeg
graft
concentr
result
indic
polym
graft
cell
surfac
dosedepend
fashion
given
cell
modifi
fluoresceinlabel
mpeg
like
cell
surfac
significantli
modifi
furthermor
trypan
blue
stain
cell
layer
demonstr
viabil
h
postmodif
flow
cytometr
studi
propidium
iodid
stain
cell
also
demonstr
signific
decreas
initi
viabil
level
h
incub
postmodif
mpeg
maximum
mm
graft
concentr
data
shown
assess
antivir
efficaci
host
cell
modif
cell
differenti
modifi
kda
svampeg
challeng
unmodifi
rgrsv
moi
shown
fig
kda
polym
ineffect
moi
graft
concentr
thu
directli
graft
kda
polym
rsv
effect
inhibit
infect
polym
graft
host
cell
antivir
effect
suggest
incap
camouflag
viral
receptor
dramat
contrast
kda
polym
demonstr
signific
antivir
prophylaxi
moi
mpeg
dosedepend
manner
note
even
high
nonbiolog
moi
fig
signific
reduct
infect
note
kda
polym
graft
concentr
mm
biolog
relev
moi
fig
host
cell
graft
concentr
mm
kda
polym
yield
almost
complet
protect
viral
infect
importantli
moi
graft
concentr
mm
kda
mpeg
target
cell
result
signific
decreas
viral
infect
rel
posit
control
mm
entir
h
incub
period
suggest
mpeg
graft
host
cell
dramat
inhibit
initi
viral
invas
also
prevent
spread
infect
progeni
viru
import
indic
graft
mpeg
barrier
remain
intact
h
incub
time
moreov
lower
moi
ie
approxim
natur
inocul
dose
find
indic
mpegmodif
host
cell
would
reduc
complet
prevent
infect
vivo
previous
discuss
rsv
preferenti
infect
polar
epitheli
cell
vivo
confirm
find
nonpolar
cell
antivir
effect
membran
graft
kda
svampeg
mm
polar
mdck
cell
assess
demonstr
fig
signific
reduct
p
rgrsv
infect
observ
inde
rel
control
mm
infect
reduct
seen
h
respect
furthermor
number
infect
cell
doubl
h
mm
control
increas
level
infect
mm
graft
concentr
inde
slight
decreas
number
infect
cell
observ
like
due
death
initi
infect
cell
find
nonpolar
hela
cell
demonstr
mpeg
antivir
barrier
host
cell
surfac
stabl
abl
inhibit
infect
progeni
viru
therebi
prevent
secondari
infect
find
suggest
mpegmodif
nasal
epitheli
cell
may
capabl
produc
highli
effect
antivir
barrier
base
previou
viral
studi
evalu
mpegmodif
rsv
mean
inhibit
rsv
infect
use
plaqu
assay
rgrsv
infect
hela
cell
show
mpeg
graft
inhibit
rsv
infect
dosedepend
manner
broad
rang
viral
dose
furthermor
also
demonstr
mpeg
graft
rsv
prevent
infect
polar
cell
dramat
disrupt
integr
rsv
virion
use
plaqu
assay
observ
svalink
confer
highest
level
virusinactiv
like
result
prolong
hydrolysi
halflif
linker
chemistri
svampeg
hydrolysi
halflif
min
scmpeg
cmpeg
hydrolysi
halfliv
min
min
respect
thu
activ
svampeg
remain
solut
min
derivat
reaction
therebi
give
rise
enhanc
graft
per
viral
particl
longer
hydrolysi
halflif
svalink
chemistri
like
underlay
observ
decreas
effect
polym
size
vs
kda
note
svampeg
lower
graft
concentr
import
linker
chemistri
also
appar
examin
previou
studi
mpegmodifi
adenoviru
gene
therapi
vector
studi
pegyl
condit
chosen
optim
modifi
virion
remain
infecti
howev
similar
find
modif
adenoviru
high
level
prolong
period
cmpeg
succinimidyl
propion
mpeg
spampeg
dramat
decreas
host
cell
infect
studi
indic
decreas
infect
observ
cmpeg
result
crosslink
sever
virion
bifunct
cmpeg
molecul
howev
tem
studi
svampeg
littl
viru
aggreg
observ
addit
studi
mpegmodifi
adenoviru
also
shown
modif
viru
treysl
mpeg
tmpeg
dramat
blunt
infect
vitro
vivo
find
surpris
tmpeg
graft
lower
densiti
rel
cmpeg
scmpeg
previou
studi
laboratori
shown
tmpeg
rel
poor
camouflag
cell
surfac
epitop
white
blood
cell
thu
appear
tmpeg
linker
chemistri
high
level
protein
modif
readili
achiev
result
virion
would
heavili
modifi
would
still
capabl
infect
host
cell
polym
length
independ
linker
chemistri
may
also
effect
base
structur
viru
note
fig
scmpeg
svampeg
shorter
polym
show
trend
toward
enhanc
protect
long
chain
polym
lower
graft
concentr
ie
viru
particl
polym
ratio
low
low
viru
mpeg
ratio
improv
efficaci
kda
polym
may
partial
due
distribut
viru
specif
protein
within
viral
envelop
rsv
virion
g
attach
f
fusion
protein
form
glycoprotein
spike
nm
apart
extent
nm
virion
surfac
previou
studi
mpeg
polym
graft
artifici
surfac
shown
kda
mpeg
extend
nm
surfac
kda
mpeg
extend
nm
surfac
estim
length
base
mpeg
highli
flexibl
molecul
graft
mpeg
chain
inhibit
larg
molecul
particl
ie
mpeg
chain
antibodi
cell
interact
cell
surfac
within
radiu
polym
thu
given
distanc
glycoprotein
spike
rsv
virion
graft
kda
mpeg
like
result
direct
modif
greater
number
glycoprotein
spike
graft
kda
mpeg
like
result
fewer
spike
modifi
initi
bound
mpeg
exclud
polym
chain
graft
spike
close
proxim
higher
graft
concentr
selfexclus
effect
graft
mpeg
partial
overcom
result
high
level
surfac
modif
effect
enhanc
svampeg
due
longer
halflif
antivir
effect
direct
modif
rsv
viru
activ
mpeg
due
disrupt
viru
particl
demonstr
tem
studi
fig
find
consist
em
studi
mpegmodifi
adenoviru
also
show
polym
graft
dramat
disrupt
integr
virion
addit
demonstr
fig
insert
actual
abil
modifi
viru
bind
target
cell
significantli
disrupt
result
decreas
intern
infect
direct
pegyl
viru
particl
might
desir
possibl
circumst
eg
blood
bank
less
biolog
use
respiratori
virus
rsv
howev
abil
produc
antivir
barrier
direct
pegyl
target
cell
eg
nasal
epitheli
cell
viru
would
signific
clinic
util
note
fig
direct
graft
kda
mpeg
polym
mammalian
cell
result
potent
antirsv
barrier
inde
higher
graft
concentr
mm
signific
protect
observ
moi
howev
polym
size
crucial
determin
antivir
effect
contrast
direct
modif
rsv
kda
polym
demonstr
efficaci
modifi
target
cell
find
somewhat
surpris
previou
studi
mpegmodifi
host
cell
virus
model
demonstr
efficaci
smaller
polym
although
larg
polym
clearli
superior
furthermor
previou
studi
surfac
charg
camouflag
antigen
mask
cell
surfac
epitop
also
show
short
long
chain
polym
confer
protect
although
larg
polym
similarli
effect
differ
find
previou
studi
like
explain
probabl
interact
rsv
current
unknown
host
cell
receptor
dramat
differ
host
cell
protect
seen
kda
mpeg
polym
find
may
provid
insight
size
rsv
receptor
kda
mpeg
graft
cell
surfac
produc
mpeg
zone
exclus
extend
approxim
nm
surfac
contrast
kda
mpeg
project
nm
surfac
theoret
estim
base
therefor
much
deeper
mpeg
zone
exclus
creat
given
differ
efficaci
two
polym
length
like
rsv
receptor
extend
nm
cell
surfac
extend
past
nm
thu
rsv
receptor
would
effect
hidden
kda
polym
remain
unprotect
kda
polym
importantli
potenti
vivo
use
direct
modif
polar
mdck
cell
also
demonstr
potent
antirsv
efficaci
thu
probabl
direct
mpegmodif
polar
nasal
epitheli
cell
confer
protect
vivo
applic
viscou
activ
mpeg
gel
nasal
caviti
suffici
modifi
epitheli
cell
within
minut
exposur
yield
effect
broad
spectrum
antivir
barrier
previous
note
antivir
prophylaxi
effect
envelop
nonenvelop
virus
howev
futur
vivo
studi
necessari
determin
prophylact
therapi
mpegbas
therapeut
would
provid
enhanc
protect
rsvmediat
diseas
rel
current
immunoglobulin
base
prophylact
therapi
find
demonstr
mpegmodif
rsv
target
cell
highli
effect
strategi
prevent
viral
infect
interestingli
kda
polym
demonstr
efficaci
modifi
rsv
particl
long
chain
polym
confer
protect
rsv
derivat
target
cell
polym
size
effect
due
size
differ
rsv
nm
hela
cell
mm
diamet
potenti
reflect
size
current
unknown
rsv
receptor
short
chain
polym
effect
virus
henc
find
suggest
activ
mpegbas
antivir
therapi
must
take
consider
known
unknown
interact
viru
host
cell
may
readili
accomplish
use
long
chain
polym
use
combin
long
short
chain
polym
speci
thu
studi
support
potenti
clinic
util
mpeg
graft
host
cell
new
broad
spectrum
antivir
prophylact
therapi
